請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/52705
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 賈景山(Jean-San Chia) | |
dc.contributor.author | Fang-Yun Lay | en |
dc.contributor.author | 賴方筠 | zh_TW |
dc.date.accessioned | 2021-06-15T16:24:03Z | - |
dc.date.available | 2020-09-24 | |
dc.date.copyright | 2015-09-24 | |
dc.date.issued | 2015 | |
dc.date.submitted | 2015-08-15 | |
dc.identifier.citation | Altenberg, B., and Greulich, K.O. (2004). Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. Genomics 84, 1014-1020. Amedei, A., Niccolai, E., and D'Elios, M.M. (2011). T cells and adoptive immunotherapy: recent developments and future prospects in gastrointestinal oncology. Clinical developmental immunology 2011, 320571. Bae, S., Kim, H., Lee, N., Won, C., Kim, H.R., Hwang, Y.I., Song, Y.W., Kang, J.S., and Lee, W.J. (2012). alpha-Enolase expressed on the surfaces of monocytes and macrophages induces robust synovial inflammation in rheumatoid arthritis. Journal of immunology 189, 365-372. Buonaguro, L., Petrizzo, A., Tornesello, M.L., and Buonaguro, F.M. (2011). Translating tumor antigens into cancer vaccines. Clinical and vaccine immunology : CVI 18, 23-34. Cannon, M.J., Schmid, D.S., and Hyde, T.B. (2010). Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Reviews in medical virology 20, 202-213. Capello, M., Ferri-Borgogno, S., Cappello, P., and Novelli, F. (2011). alpha-Enolase: a promising therapeutic and diagnostic tumor target. The FEBS journal 278, 1064-1074. Cappello, P., Rolla, S., Chiarle, R., Principe, M., Cavallo, F., Perconti, G., Feo, S., Giovarelli, M., and Novelli, F. (2013). Vaccination with ENO1 DNA prolongs survival of genetically engineered mice with pancreatic cancer. Gastroenterology 144, 1098-1106. De Leo, A.B. (2005). p53-based immunotherapy of cancer. Approaches ro reversing unresponsiveness to T lymphocytes and preventing tumor escape. Advances in oto-rhino-laryngology 62, 134-150. Dudani, A.K., Cummings, C., Hashemi, S., and Ganz, P.R. (1993). Isolation of a novel 45 kDa plasminogen receptor from human endothelial cells. Thrombosis research 69, 185-196. Feo, S., Arcuri, D., Piddini, E., Passantino, R., and Giallongo, A. (2000). ENO1 gene product binds to the c-myc promoter and acts as a transcriptional repressor: relationship with Myc promoter-binding protein 1 (MBP-1). FEBS letters 473, 47-52. Govekar, R.B., D'Cruz, A.K., Alok Pathak, K., Agarwal, J., Dinshaw, K.A., Chinoy, R.F., Gadewal, N., Kannan, S., Sirdeshmukh, R., Sundaram, C.S., et al. (2009). Proteomic profiling of cancer of the gingivo-buccal complex: Identification of new differentially expressed markers. Proteomics. Clinical applications 3, 1451-1462. Harris, C.C. (1996). Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. Journal of the National Cancer Institute 88, 1442-1455. Hennipman, A., van Oirschot, B.A., Smits, J., Rijksen, G., and Staal, G.E. (1988). Glycolytic enzyme activities in breast cancer metastases. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 9, 241-248. Hoffmann, T.K., Trellakis, S., Okulicz, K., Schuler, P., Greve, J., Arnolds, J., Bergmann, C., Bas, M., Lang, S., Lehnerdt, G., et al. (2011). Cyclin B1 expression and p53 status in squamous cell carcinomas of the head and neck. Anticancer research 31, 3151-3157. Hollstein, M., Shomer, B., Greenblatt, M., Soussi, T., Hovig, E., Montesano, R., and Harris, C.C. (1996). Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation. Nucleic acids research 24, 141-146. Ishida, H., Komiya, S., Inoue, Y., Yutani, S., Inoue, A., and Itoh, K. (2000). Expression of the SART1 tumor-rejection antigen in human osteosarcomas. International journal of oncology 17, 29-32. Katayama, M., Nakano, H., Ishiuchi, A., Wu, W., Oshima, R., Sakurai, J., Nishikawa, H., Yamaguchi, S., and Otsubo, T. (2006). Protein pattern difference in the colon cancer cell lines examined by two-dimensional differential in-gel electrophoresis and mass spectrometry. Surgery today 36, 1085-1093. Khan, A., Farah, C.S., Savage, N.W., Walsh, L.J., Harbrow, D.J., and Sugerman, P.B. (2003). Th1 cytokines in oral lichen planus. Journal of oral pathology medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 32, 77-83. Kikuchi, M., Nakao, M., Inoue, Y., Matsunaga, K., Shichijo, S., Yamana, H., and Itoh, K. (1999). Identification of a SART-1-derived peptide capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes. International journal of cancer. Journal international du cancer 81, 459-466. Kondo, H., Sahara, H., Miyazaki, A., Nabeta, Y., Hirohashi, Y., Kanaseki, T., Yamaguchi, A., Yamada, N., Hirayama, K., Suzuki, M., et al. (2002). Natural antigenic peptides from squamous cell carcinoma recognized by autologous HLA-DR8-restricted CD4+ T cells. Japanese journal of cancer research : Gann 93, 917-924. Lo Presti, M., Ferro, A., Contino, F., Mazzarella, C., Sbacchi, S., Roz, E., Lupo, C., Perconti, G., Giallongo, A., Migliorini, P., et al. (2010). Myc promoter-binding protein-1 (MBP-1) is a novel potential prognostic marker in invasive ductal breast carcinoma. PloS one 5, e12961. Majchrzak, E., Szybiak, B., Wegner, A., Pienkowski, P., Pazdrowski, J., Luczewski, L., Sowka, M., Golusinski, P., Malicki, J., and Golusinski, W. (2014). Oral cavity and oropharyngeal squamous cell carcinoma in young adults: a review of the literature. Radiology and oncology 48, 1-10. Mayordomo, J.I., Loftus, D.J., Sakamoto, H., De Cesare, C.M., Appasamy, P.M., Lotze, M.T., Storkus, W.J., Appella, E., and DeLeo, A.B. (1996). Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines. The Journal of experimental medicine 183, 1357-1365. Moscato, S., Pratesi, F., Sabbatini, A., Chimenti, D., Scavuzzo, M., Passatino, R., Bombardieri, S., Giallongo, A., and Migliorini, P. (2000). Surface expression of a glycolytic enzyme, alpha-enolase, recognized by autoantibodies in connective tissue disorders. European journal of immunology 30, 3575-3584. Nijman, H.W., Van der Burg, S.H., Vierboom, M.P., Houbiers, J.G., Kast, W.M., and Melief, C.J. (1994). p53, a potential target for tumor-directed T cells. Immunology letters 40, 171-178. Pancholi, V. (2001). Multifunctional alpha-enolase: its role in diseases. Cellular and molecular life sciences : CMLS 58, 902-920. Perconti, G., Ferro, A., Amato, F., Rubino, P., Randazzo, D., Wolff, T., Feo, S., and Giallongo, A. (2007). The kelch protein NS1-BP interacts with alpha-enolase/MBP-1 and is involved in c-Myc gene transcriptional control. Biochimica et biophysica acta 1773, 1774-1785. Piast, M., Kustrzeba-Wojcicka, I., Matusiewicz, M., and Banas, T. (2005). Molecular evolution of enolase. Acta biochimica Polonica 52, 507-513. Pratesi, F., Moscato, S., Sabbatini, A., Chimenti, D., Bombardieri, S., and Migliorini, P. (2000). Autoantibodies specific for alpha-enolase in systemic autoimmune disorders. The Journal of rheumatology 27, 109-115. Roopashree, M.R., Gondhalekar, R.V., Shashikanth, M.C., George, J., Thippeswamy, S.H., and Shukla, A. (2010). Pathogenesis of oral lichen planus--a review. Journal of oral pathology medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 39, 729-734. Schuler, P.J., Harasymczuk, M., Visus, C., Deleo, A., Trivedi, S., Lei, Y., Argiris, A., Gooding, W., Butterfield, L.H., Whiteside, T.L., and Ferris, R.L. (2014). Phase I dendritic cell p53 peptide vaccine for head and neck cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 20, 2433-2444. Schuler, P.J., Hoffmann, T.K., Gauler, T.C., Bergmann, C., Brandau, S., and Lang, S. (2013). [Immunotherapy of head and neck cancer. Current developments]. Hno 61, 559-572. Scully, C., and Bagan, J. (2009). Oral squamous cell carcinoma overview. Oral oncology 45, 301-308. Shichijo, S., Nakao, M., Imai, Y., Takasu, H., Kawamoto, M., Niiya, F., Yang, D., Toh, Y., Yamana, H., and Itoh, K. (1998). A gene encoding antigenic peptides of human squamous cell carcinoma recognized by cytotoxic T lymphocytes. The Journal of experimental medicine 187, 277-288. Sugerman, P.B., and Savage, N.W. (2002). Oral lichen planus: causes, diagnosis and management. Australian dental journal 47, 290-297. Sugerman, P.B., Savage, N.W., Walsh, L.J., Zhao, Z.Z., Zhou, X.J., Khan, A., Seymour, G.J., and Bigby, M. (2002). The pathogenesis of oral lichen planus. Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists 13, 350-365. Tomaino, B., Cappello, P., Capello, M., Fredolini, C., Sperduti, I., Migliorini, P., Salacone, P., Novarino, A., Giacobino, A., Ciuffreda, L., et al. (2011). Circulating autoantibodies to phosphorylated alpha-enolase are a hallmark of pancreatic cancer. Journal of proteome research 10, 105-112. Tsai, S.T., Chien, I.H., Shen, W.H., Kuo, Y.Z., Jin, Y.T., Wong, T.Y., Hsiao, J.R., Wang, H.P., Shih, N.Y., and Wu, L.W. (2010). ENO1, a potential prognostic head and neck cancer marker, promotes transformation partly via chemokine CCL20 induction. European journal of cancer 46, 1712-1723. Tu, S.H., Chang, C.C., Chen, C.S., Tam, K.W., Wang, Y.J., Lee, C.H., Lin, H.W., Cheng, T.C., Huang, C.S., Chu, J.S., et al. (2010). Increased expression of enolase alpha in human breast cancer confers tamoxifen resistance in human breast cancer cells. Breast cancer research and treatment 121, 539-553. Wygrecka, M., Marsh, L.M., Morty, R.E., Henneke, I., Guenther, A., Lohmeyer, J., Markart, P., and Preissner, K.T. (2009). Enolase-1 promotes plasminogen-mediated recruitment of monocytes to the acutely inflamed lung. Blood 113, 5588-5598 | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/52705 | - |
dc.description.abstract | 口腔扁平苔蘚(OLP)是一種常見的自體免疫性疾病,其表現最主要是位於頰黏膜,舌和牙齦而表徵主要是以多個白色丘疹為標準。之前研究指出,根據估計0.2%口腔扁平苔蘚將發展成口腔鱗狀細胞癌(OSCC)。口腔鱗狀細胞癌 (OSCC) 和口腔扁平苔蘚 (OLP) 都是由口腔角質細胞病變而造成。我們使用這OSCC患者的血漿進行西方墨點法實驗,我們發現口腔癌的細胞裂解物中有高度抗alpha-烯醇化酶的抗體表現。此外我們發現,alpha-烯醇化酶在OLP和OSCC組織切片中有高表現量,並且抗alpha-烯醇化酶的抗體會在在OLP和OSCC患者的血漿中有較高表現。這些結果表示,alpha-烯醇化酶可能是口腔扁平苔蘚和口腔鱗狀細胞癌的發展相關聯的自身抗原中的一個。為了去探測患者周邊血中alpha-烯醇化酶特異性T細胞,我們使用了烯醇化酶多肽池刺激OLP或OSCC患者的CD4和CD8 T細胞。從此實驗中獲得的結果表明,alpha-烯醇化酶特異性T細胞是罕見的,並且多官能反應細胞的功能相較於巨細胞病毒特異性細胞是較為低落。此外我們發現,alpha-烯醇化酶特異性T細胞在腫瘤的百分比都是比周邊血更高。我們的研究結果表明,alpha-烯醇化酶可以是腫瘤相關抗原,並且我們也發現alpha-烯醇化酶特異性T細胞在腫瘤部位尤其豐富。 | zh_TW |
dc.description.abstract | Oral lichen planus (OLP) is a common autoimmune disorder, which presents as multiple white papules at the buccal mucosa, tongue and gingivae. It’s estimated that 0.2% OLP will develop in to oral squamous cell carcinoma (OSCC). Both OSCC and OLP are lesions of oral keratinocyte. By using OLP and OSCC patients’ plasma to hybridize the oral cancer cell lysate, we found that alpha-enolase was highly expressed in OLP and OSCC tissue sections, and levels of anti-alpha-enolase antibodies were increased in both OLP and OSCC patients’ plasma. These results indicate that alpha-enolase may be one of the self-antigens associated with the development of both OLP and OSCC. To visualize alpha-enolase-specific T cells in the peripheral blood, we used an enolase peptide pool to stimulate OLP or OSCC patient’s CD4 and CD8 T cells. The results obtained from peripheral blood indicate that alpha-enolase-specific T cells are rare and exhibit impaired polyfunctional effector function, as compared to cytomegalovirus-specific cells. In addition, we found that the percentages of alpha-enolase-specific T cells in tumor are higher than in peripheral blood. Our results suggest that alpha-enolase may be a tumor-associated antigen. And alpha-enolase-specific T cells are especially enriched at the tumor site. | en |
dc.description.provenance | Made available in DSpace on 2021-06-15T16:24:03Z (GMT). No. of bitstreams: 1 ntu-104-R02449009-1.pdf: 3200069 bytes, checksum: 8592a6e4c8a60527d7a1d16df04076aa (MD5) Previous issue date: 2015 | en |
dc.description.tableofcontents | 目錄 i 表目錄 iv 圖目錄 v 致謝 vii 口試委員會審定書 ix 中文摘要 x Abstract xi Chapter 1. Introduction 1 1.1 Oral lichen planus (OLP) 1 1.2 Immune response in OLP 1 1.3 Carcinogenesis in OLP 2 1.4 Oral squamous cell carcinoma (OSCC) 3 1.5 Tumor-associated antigens for specific immunotherapy 3 1.6 Tumor-associated antigen in OSCC 4 1.7 alpha-enolase 6 Chapter 2. Purpose and Aims 8 Chapter 3. Materials and Methods 10 3.1 Isolation of Peripheral Blood Mononuclear Cells 10 3.2 Isolation of tumor-infiltrating lymphocytes (TILs) 11 3.3 Flow Cytometry Analysis 11 3.4 Cell Sorting 12 3.5 Monocyte Derived Dendritic Cells (moDC) generation 13 3.6 Peptide-specific T cells induction Assay 14 3.7 Enzyme-Linked Immunosorbent Assay 15 3.8 Immunohistochemistry 15 3.9 Western Blot Analysis 17 3.10 Statistical Analysis 17 Chapter 4. Results 19 4.1 alpha-enolase expression is increased in OLP and OSCC 19 4.2 Circulating anti-α-enolase antibody responses of OLP is higher than OSCC, RAU and healthy donor 20 4.3 alpha-enolase-specific T cells are few and lack immediate effector function in the peripheral blood 21 4.4 Utilizing moDC stimulation, alpha-enolase-specific T cells response is increased and these cells also had polyfunctionality 22 4.5 Anti-α-enolase antibody titer is correlated with the α-enolase-specific T cell response in OSCC patients 24 4.6 Percentage of alpha-enolase-specific T cells in TIL are higher than PBMC 24 Chapter 5. Discussion 25 Chapter 6. Reference 27 Chapter 7. Table 35 Chapter 8. Figures 36 | |
dc.language.iso | en | |
dc.title | 自體抗原alpha-烯醇酶在扁平苔藓和口腔鱗狀細胞癌病人中引起的適應性免疫反應 | zh_TW |
dc.title | Adaptive immune response toward α-enolase in OLP and OSCC patients | en |
dc.type | Thesis | |
dc.date.schoolyear | 103-2 | |
dc.description.degree | 碩士 | |
dc.contributor.coadvisor | 邱彥霖(Yen-Ling chiu) | |
dc.contributor.oralexamcommittee | 許秉寧(Ping-Ning Hsu),李建國(Chien-Kuo Lee) | |
dc.subject.keyword | 扁平苔?,口腔鱗狀細胞癌,alpha-烯醇?, | zh_TW |
dc.subject.keyword | OLP,OSCC,α-enolase, | en |
dc.relation.page | 58 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2015-08-15 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 免疫學研究所 | zh_TW |
顯示於系所單位: | 免疫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-104-1.pdf 目前未授權公開取用 | 3.13 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。